Over the past 20 years, Gao Wei has adhered to the policy of "pioneering and innovating, seeking truth from facts and consolidating development", taking scientific and technological innovation as the driving force and scientific management as the backing, which has promoted the sustained, rapid and healthy development of enterprises. The company has developed disposable infusion consumables, surgical sutures, implantable medical catheters, cardiac stents, indwelling needles and various special-shaped needles, blood purification series products, orthopedic series products, mechatronic medical devices, therapeutic injections, biological diagnostic reagents, artificial plasma and other medical device products and medicines in China, and established a large-scale medical product industrial park, orthopedic material industrial park, medical science and technology industrial park and aerospace electronic product production base, which has now become the largest disposable medical treatment in China.
Gao Wei Group adheres to the development strategy of "people-oriented, science and technology first", improves the scientific management mode and improves the management system. The company takes the lead in introducing and using advanced management software such as ERP and KPI in the same industry, and its products have passed the certification of CE, ISO900 1, ISO 13485, and some products have passed the marketing license of the US FDA. The company's testing center has been approved by the National Laboratory Accreditation Committee. The persistent pursuit of science and technology has given Gaowei Group room for survival and development. The company was recognized by the Ministry of Science and Technology and other ministries as "Key High-tech Enterprise of the National Torch Program", "Industrialization Base of the Achievements of the National High-tech Research and Development (863) Program" and "National Enterprise Technology Center", and a postdoctoral workstation for enterprises was established. The company actively cooperates with Changchun Institute of Applied Chemistry of Chinese Academy of Sciences, Dalian Institute of Chemistry of Chinese Academy of Sciences, Shenyang Institute of Metals of Chinese Academy of Sciences, Third Military Medical University, 30 1 Hospital, Harbin Institute of Technology (Weihai) and other scientific research institutes and institutions, and employs 10 academicians of the two academies as consultants. Gaowei Group has established nine R&D centers in various places relying on talents and scientific research strength. More than 60 products of the company have reached the advanced level at home and abroad, and many products have filled the domestic gap. Twenty products have been selected for many national projects, such as the National 863 Program, the National Key Torch Program, the National High-tech Industry Demonstration Project, and the National Key New Products. Among them, drug-coated stent systems, prefilled syringes, orthopedic implant materials and other products have broken the monopoly of foreign companies on the China market.
Gao Wei Group insists on implementing the famous brand strategy and cultivating well-known brands. Jerry's trademark was recognized as a well-known trademark in China, Jerry's disposable sterile infusion medical devices were awarded the title of famous brand products in China, and Jerry's brand was rated as the first brand of medical devices in China by China Brand Research Institute. The company has established more than 100 sales offices in more than 30 provinces, municipalities and autonomous regions, and established long-term and stable relations with more than 7,000 hospitals, more than 400 blood stations and more than 1800 commercial companies. Our products not only sell well in more than 30 provinces, municipalities and autonomous regions, but also are directly exported to more than 50 countries and regions such as the United States, the European Union, Russia, South Africa and Brazil.
Gao Wei Group will always adhere to Scientific Outlook on Development, take "creating a healthy future with white messengers" as its purpose, take disposable medical devices and medicines as its leading factor, vigorously promote the adjustment of industrial structure, product structure and institutional structure, realize the internationalization of capital, technology and management, and strive to become a world-competitive, leading and most respected medical device and pharmaceutical enterprise in Asia, making new contributions to promoting the development of medical services in China and improving people's health.